Showing results (1081-1090 of 1,557) with videos related to
Sort By:
Pageof 156
Applied and Environmental Microbiology|August 13, 2013
U(VI) reduction by diverse outer surface c-type cytochromes of Geobacter sulfurreducensRoberto Orellana, Janet J Leavitt, Luis R Comolli, et al.Molecular Cancer Therapeutics|December 4, 2013
Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 lossEllen M Beauchamp, Brittany A Woods, Austin M Dulak, et al.Molecular Cancer Therapeutics|October 17, 2013
Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cellsHelena Mistry, Grace Hsieh, Sara J Buhrlage, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2016
Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung CancerCurtis R Chong, Magda Bahcall, Marzia Capelletti, et al.Breast Cancer Research and Treatment|July 3, 2025
A single bout of resistance or high-intensity interval training increases anti-cancer myokines and suppresses cancer cell growth in vitro in survivors of breast cancerFrancesco Bettariga, Dennis R Taaffe, Cristina Crespo-Garcia, et al.Cancer Discovery|June 4, 2015
Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung CancerErin M Tricker, Chunxiao Xu, Sharmeen Uddin, et al.Medicine and Science in Sports and Exercise|September 3, 2025
Effects of Resistance vs High Intensity Interval Training on Myokines and Cancer Cell Suppression in Breast Cancer Survivors: A Randomized TrialFrancesco Bettariga, Dennis R Taaffe, Cristina Crespo-Garcia, et al.Biorxiv : the Preprint Server for Biology|April 1, 2025
Rewiring the fusion oncoprotein EWS/FLI1 in Ewing sarcoma with bivalent small moleculesMichael J Bond, Ryan P Golden, Giulia DiGiovanni, et al.Proceedings of the National Academy of Sciences of the United States of America|January 9, 2021
Mammalian cell proliferation requires noncatalytic functions of O-GlcNAc transferaseZebulon G Levine, Sarah C Potter, Cassandra M Joiner, et al.Leukemia|November 23, 2016
Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathwayY Shen, C S Park, K Suppipat, et al.Pageof 156